PlainPharmaWatch

CMS Open Payments · Program Year 2024

Xenco Medical LLC

Xenco Medical LLC reported $11,494.84 across General Payments, Research, and Ownership to 5 physicians and teaching hospitals across 5 transactions.

$11.5K
All-tracks total
5
Transactions
5
Recipients
−$6.0K
General Payments vs PY2023

Xenco Medical LLC reported $11,494.84 across all CMS Open Payments tracks (General + Research + Ownership) to 5 physicians and teaching hospitals in Program Year 2024 - ranking #1625 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $11,494.84, averaging $2.3K per recipient.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

CMS Sunshine Act warrant

Manufacturer xenco-medical-llc Xenco Medical LLC

$11.5K · #1625/1,925 · 0.0% industry · PY2024

  • TOT $11.5K
  • RANK #1625
  • SHARE 0.0%
  • TXN 5
  • RCP 5
  • CAT 3
  • GEN $11.5K
  • ΔGEN −$6.0K
  • TOP1 100.0%
  • PY 2024

Nearest volume peer: Maxx Health Inc ($11.5K)

Greiner Bio-One North Americ…$11.6KBiobeat USA Inc.$11.6KBiolase MG LLC$11.5KXenco Medical LLC (this)$11.5KMaxx Health Inc$11.5K
All-tracks payment totals near Xenco Medical LLC (CMS Open Payments PY2024)

Xenco Medical LLC sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →

Release-over-release change

General Payments changed from PY2023 to PY2024

Xenco Medical LLC's CMS-reported General Payments decreased by $6.0K (−34.3%) from PY2023 to PY2024.

How this year-over-year comparison is scoped

The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.

CMS source labels for this exact identifier: PY2022: XENCO MEDICAL LLCPY2023: XENCO MEDICAL LLCPY2024: Xenco Medical LLC. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$17.5KPY2024$11.5K
PY2023
$17,500.00
PY2024
$11,494.84

What the Data Shows for Xenco Medical LLC

$11,494.84: that is what Xenco Medical LLC reported in payments to 5 physicians and teaching hospitals during Program Year 2024, spread across 5 transactions ($2.3K per transaction, $2.3K per recipient). The company sits at rank #1625 of 1,925, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.

The 3-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Consulting Fee" at $9.5K, accounting for 82.6% of this company's General Payments and 3 transactions.

General Payment Breakdown by Type

Xenco Medical LLC made 3 types of general payments. "Consulting Fee" is the largest category at $9.5K, 82.6% of General Payments.

How Xenco Medical LLC divides its payments

Ranked by total dollars reported per category

1. Consulting Fee$9.5K2. Compensation for Services…$1.5K3. Travel and Lodging$494.84
Payment Type Amount Transactions
Consulting Fee $9.5K 3
Compensation for Services Other Than Consulting $1.5K 1
Travel and Lodging $494.84 1

Recipient Concentration in General Payments

The five largest recipient relationships account for $11,494.84 (100.0%) of $11,494.84 in this company's General Payments records across 1 recipients.

General Payments scope note

Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Xenco Medical LLC

The five named recipients with the highest reported General Payments from this company

Ali Chahlavi$11.5K
  1. 1

    Ali Chahlavi

    $11,494.84 across 5 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Similarly Concentrated Companies

Companies whose General Payments are spread across recipients about as (un)evenly as Xenco Medical LLC's, measured by the same HHI concentration index above, not by payment size.

What HHI 2,500 means here

2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Xenco Medical LLC.

Companies with Similar Payment Volumes

Open a profile or compare a similar company's CMS-reported payment pattern with Xenco Medical LLC.

Showing 6 of 1,924 companies with CMS-reported payment data.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

View saved (companies)
Download Xenco Medical LLC's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.